Pack Ventures — Full Portfolio
4 tracked investments · listed companies and verified rows first
Accipiter Biosciences uses computational protein design to develop de novo, single-agent protein therapies that engage multiple cell-surface receptors at once, functioning as agonists.
AI & Machine LearningBiotechDeep TechSeattle, US
Matthew Bick(Executive Officer, Director, Promoter)inJavier Castellanos(Executive Officer, Director, Promoter)Hector De Jesus Rincon Arano(Executive Officer, Promoter)Heather Redman(Director)Randall Schatzman(Director)William Canestaro(Executive Officer)
PartnerKen Horenstein· solo GP
Co-investorsArgonautic VenturesColumbus Venture PartnersWRF Capital
Hearvana is developing acoustic intelligence technology aimed at enhancing listening capabilities for both humans and machines.
AI & Machine LearningDeep TechHardware
Shyam Gollakota(Founder)Malek Itani(Founder)inTuochao Chen(Founder)
Co-investorsAllen Institute for AI (AI2) IncubatorAscend Venture CapitalJ4 VenturesPoint72 VenturesSCB 10XAI2 Incubator+5 more
LifeAt is a digital focus and productivity platform offering virtual environments, planning tools, and focus modes designed to help individuals concentrate while working or studying.
ConsumerFuture of WorkSaaS
Marisa C(Founder)
Co-investorsTRAC (Third Round Analytics Capital)Z Venture CapitalPioneer Square LabsSv Tech Ventures, Inc.
NLM Photonics develops hybrid organic electro-optic modulation materials and devices that integrate into silicon photonics and other photonic integrated circuit platforms to improve modulation efficiency and reduce power consumption.
Deep TechHardwareNew MaterialsSemiconductorsSeattle, US
Gerard Zytnicki(Co-Founder & Corporate Advisor)inPaul Nye(Co-founder)Delwin Elder(Co-founder)Lewis E. Johnson(Co-Founder & Chief Technology Officer)inBruce H. Robinson(Co-Founder & Technical Advisor)inBrad Booth(Chief Executive Officer & Board Director)in
Co-investorsEmerald Technology Ventures AgOregon Venture FundStoryHouse
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.